IASLC

Registration is open for the 2025 Hot Topic in Basic & Translational Science meeting!
See the outstanding faculty lineup and secure your seat today:
bit.ly/48epcNd

Getting ready for #IASLC Asia Conference on Lung Cancer this week!

Want to know more about #JTO #JTOCRR publications or Reviewer Workshop? Happy to connect in person.

#ACLC25 @iaslc.bsky.social @jtoonline.bsky.social @elsevierhms.bsky.social #PeerReview #ScholarlyPublication

IASLC Launches the African Impact Grants to Support Projects that Advance Lung Cancer Research - OncoDaily IASLC Launches the African Impact Grants to Support Projects that Advance Lung Cancer Research / cancer, IASLC, International Association for the Study of

IASLC Launches the African Impact Grants to Support Projects that Advance Lung Cancer Research

@iaslc.bsky.social

oncodaily.com/voices/iaslc...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

2026 is around the corner!

Present your work at IASLC’s 2026 Targeted Therapies of #LungCancer meeting #TTLC26 in Huntington Beach, CA 🏄.

Connect with peers and help shape future therapies.

🔬 Abstract submission now open!
📝 Submit now: bit.ly/3KBsUGC

The September 25 issue of The ASCO Post features insights from @iaslc.bsky.social's WCLC and ASCO 2025, perspectives on palliative care integration, geriatric inclusivity in cancer trial data, accelerated aging in childhood cancer survivors, and MORE

Full issue here: ascopost.com/issues/septe...

Perioperative Nivolumab Proves Safe, Effective for Patients with Resectable Early-Stage NSCLC - ILCN.org (ILCN/WCLC) Dr. Jonathan Spicer shared patient-reported outcomes data from CheckMate 77T showing the regimen is both safe and tolerable for patients.

♟️ CheckMate for perioperative nivolumab? Dr. Jonathan Spicer presented the latest data from the CheckMate 77T trial at #WCLC25.

🔗 Read more in ILCN: bit.ly/46m612v

Ivonescimab-Chemotherapy Combo Shows Promise as Post-TKI Option in EGFR-Mutant NSCLC - ILCN.org (ILCN/WCLC) Dr. Jonathan W. Goldman reported that ivonescimab plus chemotherapy yielded a consistent PFS benefit across subgroups.

Could ivonescimab plus chemo be a promising post-TKI option in EGFR-mutant NSCLC? 🤔

🔗 Read the highlights from #WCLC25 in ILCN
#LCSM

#WCLC25 It takes a village!

Thanks to all our dedicated editors, reviewers, our publisher and my editorial office teams! Thanks for the support from our authors and @iaslc.bsky.social!

@jtoonline.bsky.social @elsevierhms.bsky.social #JTO #JTOCRR

Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy - ILCN.org (ILCN/WCLC) Dr. David Planchard said the findings support a combination approach as a first-line treatment with an extended overall survival advantage for patients with EGFRm advanced NSCLC.

🚨 Breaking from #WCLC25: Final OS results from the FLAURA2 trial.
🔗 Read the highlights from the first Presidential Symposium in ILCN: bit.ly/48l4oU2

#LCSM

A fresh episode of LCC is out!

Dr. Alona Zer moderates a conversation with Dr. Haitam Nasrallah, Dr. Jair Bar, and Dr. Ory Wiesel on the major takeaways from #WCLC25, including clinical advances, research highlights, and global perspectives on lung cancer.

Start Listening: bit.ly/48l1M8E

Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection - ILCN.org (ILCN/WCLC) Dr. Mariano Provencio said the results could potentially define a standard adjuvant treatment for patients with resectable ES-NSCLC; however, longer-term observation is needed.

Dr. Mariano Provencio said the results could potentially define a standard adjuvant treatment for patients with resectable ES-NSCLC.

🔗 More in ILCN: bit.ly/4nyjauW

LCC in Mandarin: WCLC 2025 Highlights | IASLC The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer resear ...

What were the biggest research stories at #WCLC2025?
In this Mandarin episode of Lung Cancer Considered, Dr. Chunxia Su speaks with Dr. Yang Xia and Dr. Nan Bi about the most impactful findings from this year’s conference.

🎧 Listen here: bit.ly/3Il284D

#IASLC #LungCancer #WCLC2025 #Oncology

🛎️ Auction extended to Sept 21!
Support lung cancer research and score amazing prizes, from a Maui escape to mentoring with Dr. David Carbone.
💙 All proceeds support early-career investigators via the IASLC Foundation.
Bid before Sept 21: bit.ly/47H0swO

#IASLC #AuctionForACause #LungCancerResearch

Live From WCLC 2025: Monday Highlights | IASLC In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. Tin ...

What were the key highlights from #WCLC25 on Monday?

In this #LungCancerConsidered episode, @narjustflorezmd.bsky.social & @stephenvliu.bsky.social discuss NADIM ADJUVANT, VATS vs lobectomy, and EA5181/LS SCLC results with leading experts.

🎧 bit.ly/WCLC25Mon

Adding Value to Lung Cancer Care: Targeted Therapies - ILCN.org (ILCN/WCLC) In a Q&A with ILCN, Gisele Fraga Moreira discusses the role of targeted therapies in lung cancer care and managing toxicities with new treatments.

⭐ #WCLC25 Presenter Spotlight: Gisele Fraga Moreira will discuss the role of targeted therapies in lung cancer treatment and emphasize the need for a multidisciplinary and personalized approach to managing new toxicities.

🔗 Learn more in ILCN: bit.ly/3JPZPXA

#LCSM

The IASLC–Lancet Commission: a transformative global approach to lung cancer The outlook for patients with lung cancer has improved substantially in recent decades. There has been remarkable progress in lung cancer control with pathbreaking scientific discoveries and technolog...

📢 Announcing the @iaslc.bsky.social—Lancet Commission: a transformative approach to lung cancer.

"Our Commission is determined to frame lung cancer not merely as a disease, but as a global health problem that can be tackled."

Read on ⤵️
tinyurl.com/48e7pbrx #WCLC25

Other Than Cigarettes: The Other Tools and Status of the Art - ILCN.org (ILCN/WCLC) Enrica Capelletto, MD, PhD, aims to raise awareness about alternatives to conventional smoking to prevent nicotine dependence.

⭐ #WCLC25 Presenter Spotlight: Enrica Capelletto, MD, PhD, aims to raise awareness about alternatives to conventional smoking. 🚭

Learn more in ILCN: www.ilcn.org/other-than-c...

#LCSM

I'm in Barcelona, Now What? — Tips for First-Time WCLC Attendees | IASLC In this episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu share tips for first-time attendees of the World Conference on Lung Cancer (WC ...

First time at #WCLC25? 🎉

In this episode of #LungCancerConsidered, @narjustflorezmd.bsky.social & @stephenvliu.bsky.social share 10 tips to help attendees get the most out of the meeting, including how to work in a bit of self-care!

🎧 bit.ly/WCLC1st

2025 Distinguished Service Award Recipients Recognized During Opening Plenary - ILCN.org (ILCN/WCLC) Drs. Pasi A. Jänne, Witold Rzyman, Sanja Dacic, and Solange Peters were celebrated for their outstanding contributions to thoracic oncology.

The #WCLC25 Opening Plenary recognized the 2025 Distinguished Service Award Recipients.
🔗 Read the highlights in ILCN: bit.ly/3HV8wzs

Tackling the Challenges of Science Communication - ILCN.org (ILCN/WCLC) An interactive session at WCLC 2025 will explore the evolving challenges of science communication with leading experts in the field.

An interactive #WCLC25 session will explore the evolving challenges of science communication.

🔗 Read a preview in ILCN: www.ilcn.org/tackling-the...

Exciting news: Thoracic Circle is officially live! 🎉
Our new online community makes it easier than ever to connect, share, and engage with colleagues around the world.
Your invite should be in your inbox — or you can join now at community-iaslc.org.

Third Annual Amazing Case Race Returns for WCLC 2025 - ILCN.org (ILCN/WCLC) Kelly Nevins, IASLC Director of Education, says the competition for early-career investigators puts education in the hands of learners.

Kelly Nevins, IASLC Director of Education, says the Amazing Case Race at #WCLC25 puts education in the hands of learners.

🔗 Read the preview in ILCN: www.ilcn.org/third-annual... #LCSM

On a new episode of Lung Cancer Considered, Dr. Chunxia Su hosts a Virtual Tumor Board in Mandarin with Drs. Zhengfei Zhu & Nan Wu. They explore neoadjuvant and perioperative therapy for locally advanced NSCLC in China.
🎧 bit.ly/Neoadjuvanta...

World Conference Conversations: Inside WCLC 2025 - ILCN.org (ILCN/WCLC) WCLC Conference Chair Dr. Noemí Reguart discusses how this year's program builds on multidisciplinary collaboration, the latest therapies and advances, and global perspectives in thoracic oncology.

WCLC Conference Chair Dr. Noemí Reguart discusses how this year's #WCLC25 program builds on multidisciplinary collaboration and global perspectives in thoracic oncology.
🔗 Read more in ILCN: bit.ly/4lJNcdV
#LCSM

Stay tuned from an amazing LIVE episode from the @alkpositiveinc Summit with these amazing humans. Live from San Diego it’s Lung Cancer Considered! Stephen Liu International Association for the… | N... Stay tuned from an amazing LIVE episode from the @alkpositiveinc Summit with these amazing humans. Live from San Diego it’s Lung Cancer Considered! Stephen Liu International Association for the Stud...

On a new episode of Lung Cancer Considered, Dr. @stephenvliu.bsky.social & Dr. @narjustflorezmd.bsky.social talk with Summer Farmen, Nancee Pronsati & Kirk Smith about highlights from the ALK+ Summit, advocacy, and the power of community in lung cancer. 🎧 bit.ly/ALKSummit

In this episode of #LungCancerConsidered in Greek, @drgreeklungcancer.bsky.social hosts Dr. Petros Christopoulos and Dr. Dionysis Papadatos-Pastos to discuss how ALK+ NSCLC is managed in Greece.
🎧 bit.ly/GreekALKVTB

#ALK #NSCLC

Cold tumors? Understanding STK11 and KEAP1 in NSCLC | IASLC In this episode of Lung Cancer Considered, host Dr. Narjust Florez sits down with Dr. Biagio Ricciuti and Dr. Giannis Mountzios to discuss resistance mechanisms ...

🎙️On a new episode of Lung Cancer Considered, host @narjustflorezmd.bsky.social speaks with @biagioricciutimd.bsky.social & @drgreeklungcancer.bsky.social about resistance to immune checkpoint inhibitors, STK11/KEAP1/KRAS co-mutations, and emerging NSCLC therapies. bit.ly/LCCColdTumors

Don’t miss out, Early Bird ends Sept 5!
Join us in Chicago, Dec 5–7, for #NACLC25 and be part of the conversations shaping the future of lung cancer care.
Lock in the best rate now: bit.ly/4mIVmV1 @ascocancer.bsky.social

#LungCancer #Oncology #MedicalConference

At the IASLC 2025 Hot Topic Meeting, we’re diving into the biology, biomarkers, and breakthroughs that can transform prevention and treatment.
Join the conversation shaping the future of lung cancer research.
Register now: bit.ly/4oEkZIq

#LungCancerResearch #Oncology #HT25

LCC in Arabic: Arabic Women’s Voices in Thoracic Oncology | IASLC As part of IASLC’s ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and Dr. Maya ...

In this episode of #LungCancerConsidered in Arabic, @naglaakarimmd.bsky.social talks with Dr. Asrar AlAhmadi and Dr. Maya Khalil about the experiences and career paths of Arabic women in thoracic oncology.

🎧 Listen now: bit.ly/ArabWomenTO